GUELPH, ON, Oct. 5 /CNW/ - BIOREM Inc. ("Biorem" or "the Company") (TSX-V: BRM) announced today that it has been awarded an advanced biofiltration project valued at $720,000. Under the terms of the agreement, Biorem will supply a two-stage air emissions control system ("the System") to remove the odorous compounds from the air at a municipal wastewater treatment facility located in southern British Columbia. The System, which includes a biotrickling filter followed by a biofilter with Biorem's permanent XLD media, is expected to treat approximately 9,000 cubic meters of complex contaminated air sources per hour. The System is expected to be fully operational in the second quarter of 2010.
"Odor and emissions control is increasingly becoming a key consideration for municipal and industrial companies, as air quality at the boundary of the site becomes progressively more regulated by legislators," said Peter Bruijns, President and CEO. "We are pleased by this contract win and are excited by the opportunity to increase our footprint in western Canada. We believe that this new project is further evidence of the market's recognition of Biorem as a leader in odor control in North America and in the quality and efficiency of our systems."
About BIOREM Inc.
BIOREM designs and manufactures air emission control systems, including biofiltration and biotrickling systems that safely remove harmful contaminants such as Hydrogen Sulfide, Reduced Sulfur compounds, and Volatile organic Compounds from the air. Our systems are environmentally friendly, clean and sustainable all the while reducing greenhouse gas emissions. With more than 600 installed systems worldwide, continued extensive research efforts and over 15 years of experience, BIOREM not only offers state-of-the-art technology-based products but also peace of mind for municipalities and industrial companies and their surrounding communities. Additional information on BIOREM is available on our website at www.biorem.biz.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
This press release contains forward-looking statements based on current expectations. These forward-looking statements contain various risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties about the Company's business are more fully discussed in the disclosure materials, financial statements and MD&A filed with the securities regulatory authorities in Canada on www.sedar.com
"Order Bookings" and "Order Backlog" do not have any standardized meaning prescribed by Canadian generally accepted accounting principles ("GAAP") and may not be comparable to measures presented by other companies.
Order Bookings and Order Backlog are non-GAAP measures that the Company uses to evaluate its sales performance. Order Bookings are those binding contracts that the Company enters into with a third party for the delivery of our products or services. As Order Bookings are received, the contract value (before any associated sales taxes) is included in the Order Backlog. The Order Backlog is reduced by the revenue that is recognized on each project.
SOURCE BIOREM Inc.
For further information: For further information: Ed Corbett, Chief Financial Officer, BIOREM Technologies Inc., firstname.lastname@example.org, Tel: (519) 767-9100 x275; Adriana Braczek, Investor Relations, The Equicom Group Inc., email@example.com, Tel: (416) 815-0700 x240